MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%
Sector Heatmap
Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%
OSTX — OS Therapies Incorporated
NYSE AmericanOS Therapies Incorporated
$1.55
+0.06(+4.03%)
- O
- 1.50
- H
- 1.57
- L
- 1.46
- V
- 569.55K
⏱️ End-of-day dataAs of Oct 7, 2026
OSTX — Latest News & Headlines
7 StoriesOSTX Stock Holds Tight Range As Traders Probe Weak Financials - StocksToTrade
OSTX Stock Holds Tight Range As Traders Probe Weak Financials StocksToTrade
OS Therapies has received over $3M in tax refunds and accrued over $7M in research tax credits. - Stock Titan
OS Therapies has received over $3M in tax refunds and accrued over $7M in research tax credits. Stock Titan
72.7% of treated patients survived three years, versus 45.8% in historical comparisons. - Stock Titan
72.7% of treated patients survived three years, versus 45.8% in historical comparisons. Stock Titan
OS Therapies Reports Significant Three-Year Survival Data for Bone Cancer Treatment - Benzinga
OS Therapies Reports Significant Three-Year Survival Data for Bone Cancer Treatment Benzinga
A dog cancer treatment could launch in the U.S. in 2027, OS Therapies hopes - Stock Titan
A dog cancer treatment could launch in the U.S. in 2027, OS Therapies hopes Stock Titan
ZTG Should I Buy - Intellectia AI
ZTG Should I Buy Intellectia AI
OS Therapies bolsters leadership team amid commercialization push - TipRanks
OS Therapies bolsters leadership team amid commercialization push TipRanks